scott gottliebment he'll gottlieb. he'll be taking questions about his tenure and why he left. >> left is aaron cohen. he's the president of aaron cohen, pr. alicia munday, a writer at washington monthly magazine. john hilkirk, senior editor for independent kaiser health news. lori russo, president at stanford communication and co-lead. giving over the podium, we have a senior reporter at med tech insight and a member of the board of governors of the national press club. he's actually the vice chair. skipping over our speaker for a moment, we have anna edny. she is a health policy reporter at bloomberg news. william pierce, bill pierce, he's the senior director and headline team member who organized today's event. next to bill is steve usdon. he's a washington editor at bio sentry. and we have joyce freedman at med page today. thank you, everybody, for being here. [ applause [ applause ] >> i also want to take a moment to acknowledge the additional members of our headliners team for organizing today's event. that's dia

scott gottlieb, former fda commissioner talking about this time of the agency at 1:00 p.m.he complete guide to congress is now available with lots of details about the house and senate for the current session of congress. contact them biography information about every senator and congressional committees, state governors, and the cabinet. the 2019 congressional directory is a handy spiral-bound guide, order your copy from the c-span online store for $18.95. >> at the white house, president trump talked about efforts to cut down on unexpected medical bills. he responded to reporters questions about subpoenas presented to his son, donald trump, jr. in relation to the russia investigation. as well as questions about trade relation with china, u.s. policy in iran, and his relationship with john bolton. this is about 45 minutes. inutes. president trump: hello everybody.

scott gottlieb talked yesterday about his tenure at the agency. he also spoke about the crackdown on teen e-cigarette use and medicare and drug pricing. he also talked about challenges he faced at this national press club event. >> good afternoon. welcome to the national press club. i am a correspondent at npr news and the 112th president of the national press club. we have a terrific program today and we invite you to listen, watch, or follow along on twitter using #npclive. for our c-span and other broadcast audiences, please be were that today in the room have an audience and working press so any applause is not necessarily from working journalist. please hold your applause until everyone has been introduced. to my far left is the president of aaron cohen pr. next we have a writer from washington monthly magazine, next senior editor for enterprise extra health news, news, next president of headline team co-lead and next a senior reporter at med tech insight and a member of the board of governors of the national press club. he is actually the vi

today with big names making big headlines including strong comments from former fda commissioner scott gottliebthat's where we find tyler mathisen. >> kelly, thank you, it's been a very interesting morning we kicked off as we did last year with an interview that me a conducted with scott gottlieb, now the former commissioner of the food and drug administration one of the topics that comes up practically every time we talk to him are the e-cigarettes and how the fda responded to them and what he thinks is going on there. it was a very interesting exchange. >> gottlieb made tobacco a signature issue of his two years as fda commissioner and one of the things that he talked a lot about was providing e-cigarettes or making sure that e-cigarettes were an option for adults who already smoke and could potentially move off combustible cigarettes onto e-cigarettes but at the same time tried to balance that access with the idea that youth might try their first nicotine product in an e-cigarette. i asked him if he struck the right balance by doing that as commissioner, and he said no, that was something th

and it's deeply concerning that people were exposed this shouldn't have happened >> reporter: scott gottlieb was fda commissioner when the recalls began and says it is unlikely the contamination would have been found on a routine inspection >> if you didn't know to look for this, this would have been very hard to detect. >> reporter: in a statement, the fda says it is investigating the root causes of the contamination. and that the overall cancer risk to individual patients is small little comfort for denise shrek >> i have a 13-year-old son who's worried about his mom, you know he shouldn't have to worry about a probable carcinogen in your medication the fda in 2017 warns the problem is much bigger than just blood pressure pills >> after seeing this recall, i wondered to myself what about all the other drugs that you haven't tested >> reporter: not just these plants >> correct this is from my perspective, this is only the tip of the iceberg. >> reporter: the generic drugmakers association told us their drugs are safe regardless of where they are made, and they're working closely with the fd

scott gottlieb talked yesterday about his tenure at the agency. he also spoke about the crackdown on teen e-cigarette use and medicare and drug pricing. he also talked about challenges he faced at this national press club event. >> good afternoon. welcome to the national press club. i am a correspondent at npr news and the 112th president of the national press club. we have a terrific program today and we invite you to listen, watch,

gottlieb joins us now from the conference this morning. scottg us. >> thanks for having me. thanks. >> let's talk about the new cures that are out there there are some really exciting things that are happening in science right now. what are some of the most promising? >> yeah, i think we're at the cusp of being able to cure a lot of inherited diseases and pediatric diseases you look at things like hemophilia or sickle cell disease, even rare pediatric disorders like muscular dystrophy, sma we're really at the cusp of being able to cure these things with things like gene therapy and gene editing but what we need to do -- the challenge is that a lot of these diseases actually perpetuate poverty because they lead to disability that actually forces people into programs like medicaid and medicare disability because people aren't able to work, sometimes families aren't able to work because they're caring for a child and the risk is that the insurance pools, like medicaid, are going to be hard pressed to pay for these things so the very diseases that c

i spoke to scott gottlieb who is a former f.d.a. commissioner about this issue, and i talk to others. we need to do everything we can heror support efforts to try to come up with medication that can assist with regard to the treatment for the psychostimulant drugs. finally, we've got to be sure that communities have more flexibility to use the federal funding they are getting through cures, through the state opioid response groonts to address issues -- grants to address issues like meth. i'm exploring whether legislation is necessary for that. i believe a lot can be provided through the state grants. i will ensure that the federal government is a better partner for those working on the front lines of this drug epidemic. opioids, yes, we need to keep up the fight. we're finally making progress after eight years of increases in opioid deaths, finally last year for the first time in eight years we're seeing a reduction of those deaths, the worst drug epidemic in the history of our country. it is a time to focus on what is working and d

. >>> and coming up live here on c-span3 in about an hour, former fda commissioner scott gottlieb will be speaking and taking questions at the national press club. that's live at 1:00 eastern. you can also follow our coverage live online at c-span.org or use the free c-span radio app. >>> two members of congress joining us this morning to talk about their newly formed caucus and the role that veterans play. this is representative jimmy panetta of california and representative don bacon of nebraska, republican from that state. both of them representing the four country caucus. both serve as co-chairs. good morning to both of you. talk a little bit about the formation of this caucus, particularly its name and what you plan to do with it. >> look, i think, you know, during my last term and my first term, it got to a point where the only bipartisanship you were seeing was when you would turn on the tv was about funerals of statesmen, be it john mccain, george h.w. bush, or john dingell recently. we wanted people to understand there were members in congress who were not just here to make a

the food and drug administration -- and the -- as the food and drug administrator at the time, scott gottlieb, announced there's a plan to increase availability. it would focus on increasing competition by reducing delatos entry, improving efficient city -- efficient soif the biosimilar development and develop a communications strategy to promote biosimilars. the purple book plays an important role in biosimilar development. it lists the licensed biologic products including any biosimilar or interchangeable biologic product and any relevant exclusivity information. the purple book is not currently required by law and takes the form of two separate and sometimes cumbersome p.d.f. files. h.r. 1520 codifies the purple book and requires the food and drug administration to publish the information in a searchable format similar to the orange book. this bill will make the purple book a more useful tool for developers of biosimilars in addition to providers, payers and patients. the food and drug administration provided us with important feedback that would ensure that the agency will be able to effe

. >> reporter: scott gottlieb, fda commissioner when the recalls began and says it is unlikely the contamination found on a routine inspection. >> if you didn't know to look for this it would have been very hard to detect. >> reporter: in the statement the fda says it is investigating the root causes of the contamination and that the overall cancer risk to individual patients is small. little comfort for denise. >> i have a 13-year-old son who's worried about his mom. you know? he shouldn't have to worry about a probable carcinogen in your medication. >> reporter: this man who left the fda in 2017 warns the problem is much bigger than just blood pressure pills. >> after seeing this recall, i wonder to myself, what about all the other drugs you haven't tested? >> not just these plants? >> correct. this is, from my perspective, this is only the tip of the iceberg. >> reporter: the generic drugmakers association told us their drugs are safe regardless where they're made and working closely with the fda. and the drug economy in china also says it's working with regulators. the company in india that

for more on the hearing today, former fda commissioner scott gottlieb, also a cnbc contributor. ot the stuff that makes you high in pot, but it is supposedly something that has some medicinal qualities >> well, it does have medicinal qualities. as an approved drug, it's derived from cannabis, does the don't think it can't make you high. >> really? >> the cbd dried from cannabis, some of it does have thc in it when we analyze it, there are high concentrations of thc in it part of the problem is it's hard to differentiate the cbd derived from hemp which wouldn't have thc, to that derived from cannabis, which would have thc. >> how do you regulate that? what's legal >> that's the problem. there's more hemp growers now wanting to put cbd oil into the market because it's perceived as a high-margin derivative of hemp, so you'll have more cbd in the market and it will be hard for regulators to differentiate from the cbd derived from cannabis versus hemp and what is derived from cannabis could have high levels of thc in it the dogs have a hard time differentiating it -- >> dogs? what do

. >> reporter: scott gottlieb, was at the fdass comminer when it began and says it was unlikely it wouldd have been hard to detect. >> reporter: the fda is investigating the root causes of the contamination a the overall cancer risks to individual patients is small. little comfort for denise. >> i have a 13-year-old son who is worried about his mom, you know, he shouldn't have to worry about a possible carcinogen i your medication. >> reporter: he left the fda in 2017, says itmuch bigger than blood pressure pills. >> i worry about all the other drugs you haven't tested. >> not just these plants? >> correct. from myperspective, this is only the tip of the iceberg. >> reporter: the generic drug ti makers associa says their drugs are safe regardless of where they are made. they are working closely with the fda. th drug company in china says it is working with gulators. as far as a company in india shredding the documents, they did not respond to our questions, guys. >> what should people do if they are taking theseti medica? zplits soup were important. the fda says do not stop taking it abr

and this morning former fda commissioner scott gottlieb telling us on stage he thought that was a horribled that anybody who's doing this before all of the ethics and the science around this have been worked out should be cast oust scientific community, guys. so it's a very interesting space. these companies we talked about here are not working on editing embryos. they are working on patients who have diseases and there wouldn't be any sort of inheriting of the genome kays that are being edited in here but a really fascinating conversation there's a lot more coming up at healthy returns including a conversation with j & j ceo alex gorseky. i'll bring you any highlights from thavg >> sounds great, meg on that crispr note we just talked to sean parker. we're going to play the interview next hour. he's super bullish on that space and investing heavily around it. did want to get your take on mallinckrodt shares plunging today. what's the story >> mallinckrodt makes this drug called axar. it's a very pricey drug. and medicaid came out and said it was going to chait way it pays for this drug so

also today, former fda commissioner scott gottlieb delivers remarks at the national press club in washingtond.c. he will be talking about prescription drug prices. 1:00said 1:00 8 p.m. -- p.m. eastern time. and here's to gillibrand meets with voters in new hampshire. watch live coverage at 1:00 p.m. on c-span2, the website, or the radio app. and the council on foreign relations in washington, d.c. holds a conversation with stacey fairs, the founder of fight action and 2018 democratic candidate for governor of georgia. at 3:30 p.m.ns eastern time on c-span2. usa today has a story by susan page, featuring barbara bush's final letter to her children. bush,ote a book, "barbara a matriarch and the making of an american dynasty." she notes that the letter was never finished to her children. dearest children, she types, i have thought of writing this for a while. these are the things she wrote she was grateful for. needless to say, i am most thankful for five men and one lady, the first item on her list of things for which she was grateful. that was a reference to her husband of 73 years, george h.

. >>> and on friday, remarks by former fda governor, scott gottlieb, on the future of the fda. and why he decided to lay. live at the national press club at 1:00 eastern on c-span three . c-span's road to the white house coverage continues with new york senator and democratic presidential candidate, kiersten jill a band. speeding to voters in goffstown, new hampshire. live at 1:00 eastern on c-span 2. that, more camping cover just presidential candidate, john delaney, holds a meet and greet event with democratic voters in hollis, new hampshire. live at 7 pm eastern on c-span. >>> on american history tv, saturday at 10 pm eastern on real america. two films from the 1970s, dealing with the vietnam war. for four years, american boys have been fighting and dying in vietnam. for 12 months, our negotiators have been talking with the other side and paris. and yet, the fighting goes on. the destruction continues. brave men still die. the time has come for some --. >> each day it becomes clear to us that we consumers must act - ask in self-defense. in defense of the health of our famili

will feature exclusives with united therapeutics ceo martine roth blatt, former fda commissioner scott gottlieber now at cnbcevents.com. >>> still to come, former white house chief strategist steve bannon says the u.s. and china are in an economic war which the u.s. cannot back down in scs l join us after the break to diusthe trade war and much more we're back in a couple minutes incomparable design makes it beautiful. state of the art technology makes it brilliant. the visionary lexus nx. lease the 2019 nx 300 for $359 a month for 36 months. experience amazing at your lexus dealer. most of us don't know how much data we use... ♪ ...but we all know we're paying too much for it. enter xfinity mobile. america's best lte with the most wifi hotspots. combined for the first time. when you're near an xfinity hotspot, you're connected to wifi, saving on data. when you're not, you pay for data one gig at a time. use a little, pay a little. use a lot, just switch to unlimited. get $250 back when you buy a new samsung galaxy. call, visit or click today. >>> we are the piggy bank that everybody likes to t

. >>> and coming up live here on c-span3 in about an hour, former fda commissioner scott gottlieb will be speaking and taking questions at the national press club. that's live at 1:00 eastern. you can also follow our coverage live online at c-span.org or use the free c-span radio app. >>> two members of congress joining us this morning to talk about their newly formed caucus and the role that veterans play. this is representative jimmy panetta of california and representative don bacon of nebraska, republican from that state. both of them representing the four country caucus. both serve as co-chairs. good morning to both of you. talk a little bit about the formation of this caucus, particularly its name and what you plan to do with it. >>

. >>> former fda commissioner scott gottlieb will deliver remarks at the press club today. on c-span 2 at 1:o 00 eastern, kir sten gillibrand meets with voterings in naimpz, it is part of our road to the white house coverage and a quick reminder watch our programs online at c-span.org or listen with the free c-span radio app. >>> two films from the 1970s dealing with the vietnam war. >> for four years american boys have been fighting and dieing in vietnam. for 12 months our negotiators have been talking with the oh side in paris and our fighting goes on, destruction kill skonts, and brave men still die. the time has come for new initiatives. >> each day it becomes clear to us that we must act in self defense in the defense of the health of our families and our society. we must stop buying war. sunday at 6:00 p.m. on american art facts. tour the lbgt rights, at the museum. >> the stonewall prayed on the gae wall street workers who socialized there. there chsz a blackmailing ring going on there, it wasn't a nice place but a place where gay people could call their own. >> and

scott gottliebment he'll gottlieb. he'll be taking questions about his tenure and why he left. >> left is aaron cohen. he's the president of aaron cohen, pr. alicia munday, a writer at washington monthly magazine. john hilkirk, senior editor for independent kaiser health ne